Search research articles
Contact Us
Filters
Showing results (141-150 of 174) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy
Harold J Burstein, Yu-Hui Chen, Leroy M Parker, et al.
European Urology Oncology
|
August 19, 2020
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
Alan H Bryce, Yu Hui Chen, Glenn Liu, et al.
JAMA Oncology
|
February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Jason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
Journal of Neuro-Oncology
|
June 26, 2015
Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases
Yufei Liu, Brian M Alexander, Yu-Hui Chen, et al.
Advances in Radiation Oncology
|
February 26, 2024
A Prospective Study Assessing the Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Oligometastatic Bone Metastases
Joyce H Lee, Diana D Shi, Kee-Young Shin, et al.
Advances in Radiation Oncology
|
May 11, 2026
Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution Experience
Shane S Neibart, Katie N Lee, Yu-Hui Chen, et al.
Annals of the Rheumatic Diseases
|
July 16, 2013
Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild-type mice
Min-Jun Huang, Liang Wang, Da-di Jin, et al.
Clinical Lung Cancer
|
December 3, 2014
Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer
Raymond H Mak, Gretchen Hermann, John H Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2017
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel
Lauren C Harshman, Yu-Hui Chen, Glenn Liu, et al.
The New England Journal of Medicine
|
August 6, 2015
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J Sweeney, Yu-Hui Chen, Michael Carducci, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 174) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy
Harold J Burstein, Yu-Hui Chen, Leroy M Parker, et al.
European Urology Oncology
|
August 19, 2020
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
Alan H Bryce, Yu Hui Chen, Glenn Liu, et al.
JAMA Oncology
|
February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Jason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
Journal of Neuro-Oncology
|
June 26, 2015
Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases
Yufei Liu, Brian M Alexander, Yu-Hui Chen, et al.
Advances in Radiation Oncology
|
February 26, 2024
A Prospective Study Assessing the Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Oligometastatic Bone Metastases
Joyce H Lee, Diana D Shi, Kee-Young Shin, et al.
Advances in Radiation Oncology
|
May 11, 2026
Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution Experience
Shane S Neibart, Katie N Lee, Yu-Hui Chen, et al.
Annals of the Rheumatic Diseases
|
July 16, 2013
Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild-type mice
Min-Jun Huang, Liang Wang, Da-di Jin, et al.
Clinical Lung Cancer
|
December 3, 2014
Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer
Raymond H Mak, Gretchen Hermann, John H Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2017
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel
Lauren C Harshman, Yu-Hui Chen, Glenn Liu, et al.
The New England Journal of Medicine
|
August 6, 2015
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J Sweeney, Yu-Hui Chen, Michael Carducci, et al.
Page
of 18